- Home
- CGTL vs CCEL Comparison
CGTL vs CCEL Comparison
Compare CGTL & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTL
- CCEL
- Stock Information
- Founded
- CGTL 2016
- CCEL 1989
- Country
- CGTL Hong Kong
- CCEL United States
- Employees
- CGTL N/A
- CCEL N/A
- Industry
- CGTL
- CCEL Managed Health Care
- Sector
- CGTL
- CCEL Health Care
- Exchange
- CGTL NYSE
- CCEL Nasdaq
- Market Cap
- CGTL 37.1M
- CCEL 39.9M
- IPO Year
- CGTL 2024
- CCEL 1997
- Fundamental
- Price
- CGTL $1.37
- CCEL $5.19
- Analyst Decision
- CGTL
- CCEL Strong Buy
- Analyst Count
- CGTL 0
- CCEL 1
- Target Price
- CGTL N/A
- CCEL $8.50
- AVG Volume (30 Days)
- CGTL 7.9M
- CCEL 14.7K
- Earning Date
- CGTL 08-15-2025
- CCEL 07-14-2025
- Dividend Yield
- CGTL N/A
- CCEL 19.49%
- EPS Growth
- CGTL 35.72
- CCEL N/A
- EPS
- CGTL 0.21
- CCEL 0.01
- Revenue
- CGTL $35,611,761.00
- CCEL $32,102,750.00
- Revenue This Year
- CGTL N/A
- CCEL $2.49
- Revenue Next Year
- CGTL N/A
- CCEL $0.95
- P/E Ratio
- CGTL $5.79
- CCEL $568.17
- Revenue Growth
- CGTL N/A
- CCEL 2.33
- 52 Week Low
- CGTL $0.81
- CCEL $4.75
- 52 Week High
- CGTL $10.59
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- CGTL N/A
- CCEL 51.22
- Support Level
- CGTL N/A
- CCEL $5.00
- Resistance Level
- CGTL N/A
- CCEL $6.35
- Average True Range (ATR)
- CGTL 0.00
- CCEL 0.31
- MACD
- CGTL 0.00
- CCEL 0.02
- Stochastic Oscillator
- CGTL 0.00
- CCEL 14.07
About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED
Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.